Magnesium for neuroprophylaxis: fact or fiction?

American Journal of Obstetrics and Gynecology

Volumn 200, Issue 6, 2009, Pages 590-594

  Cahill, Alison G ^a   Caughey, Aaron B ^b  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

cerebral palsy; magnesium; neuroprophylaxis; preterm

Indexed keywords

MAGNESIUM SULFATE; PLACEBO;

BOLUS INJECTION; CEREBRAL PALSY; CHEMOPROPHYLAXIS; CLINICAL DECISION MAKING; CLINICAL TRIAL; CONTINUOUS INFUSION; DRUG MECHANISM; DRUG RESPONSE; DRUG WITHDRAWAL; EVIDENCE BASED MEDICINE; HUMAN; LOADING DRUG DOSE; OUTCOMES RESEARCH; PERCEPTION DEAFNESS; PREMATURITY; PRIORITY JOURNAL; REVIEW; TOCOLYSIS;

CEREBRAL PALSY; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE, DISEASES; MAGNESIUM; MAGNESIUM SULFATE; PROSPECTIVE STUDIES; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 65849507273     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajog.2009.04.003     Document Type: Review

References (16)

1. Hankins G.D., and Speer M. Defining the pathogenesis and pathophysiology of neonatal encephalopathy and cerebral palsy. Obstet Gynecol 102 (2003) 628-636
2. Nelson K.B., and Grether J.K. Causes of cerebral palsy. Curr Opin Pediatr 11 (1999) 487-491
3. van de Bor M., Verloove-Vanhorick S.P., Brand R., Keirse M.J., and Ruys J.H. Incidence and prediction of periventricular-intraventricular hemorrhage in very preterm infants. J Perinat Med 15 (1987) 333-339
4. Leviton A., Kuban K.C., Pagano M., Brown E.R., Krishnamoorthy K.S., and Allred E.N. Maternal toxemia and neonatal germinal matrix hemorrhage in intubated infants less than 1751 g. Obstet Gynecol 72 (1988) 571-576
5. Kuban K.C., Leviton A., Pagano M., Fenton T., Strassfeld R., and Wolff M. Maternal toxemia is associated with reduced incidence of germinal matrix hemorrhage in premature babies. J Child Neurol 7 (1992) 70-76
6. Nelson K.B., and Grether J.K. Can magnesium sulfate reduce the risk of cerebral palsy in very low birthweight infants?. Pediatrics 95 (1995) 263-269
7. Hirtz D.G., and Nelson K. Magnesium sulfate and cerebral palsy in premature infants. Curr Opin Pediatr 10 (1998) 131-137
8. Mittendorf R., Dambrosia J., Pryde P.G., et al. Association between the use of antenatal magnesium sulfate in preterm labor and adverse health outcomes in infants. Am J Obstet Gynecol 186 (2002) 1111-1118
9. Crowther C.A., Hiller J.E., Doyle L.W., Haslam R.R., and Australasian Collaborative Trial of Magnesium Sulphate (ACTOMgSO4) Collaborative Group. Effect of magnesium sulfate given for neuroprotection before preterm birth: a randomized controlled trial. JAMA 290 (2003) 2669-2676
10. Magpie Trial Follow-Up Study Collaborative Group. The Magpie Trial: a randomized trial comparing magnesium sulphate with placebo for pre-eclampsia. Outcome for children at 18 months. BJOG 114 (2007) 289-299
11. Altman D., Carroli G., Duley L., et al., Magpie Trial Collaboration Group. Do women with pre-eclampsia, and their babies, benefit from magnesium sulphate?. The Magpie Trial: a randomized placebo-controlled trial. Lancet 359 (2002) 1877-1890
12. Marret S., Marpeau L., and Bénichou J. Benefit of magnesium sulfate given before very preterm birth to protect infant brain. Pediatrics 121 (2008) 225-226
13. Marret S., Marpeau L., Zupan-Simunek V., et al., PREMAG Trial Group. Magnesium sulphate given before very-preterm birth to protect infant brain: the randomised controlled PREMAG trial. BJOG 114 (2007) 310-318
14. Rouse D.J., Hirtz D.G., Thom E., et al., Eunice Kennedy Shriver National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. A randomized, controlled trial of magnesium sulfate for the prevention of cerebral palsy. N Engl J Med 359 (2008) 895-905
15. Doyle L.W., Crowther C.A., Middleton P., Marret S., and Rouse D. Magnesium sulphate for women at risk of preterm birth for neuroprotection of the fetus. Cochrane Database Syst Rev (2009) CD004661
16. Scifres C.M., Iams J.D., Klebanoff M., and Macones G.A. Metaanalysis vs large clinical trials: which should guide our management?. Am J Obstet Gynecol 200 (2009) 484.e1-484.e5